Janus Henderson Group Portfolio holdings
Janus Henderson Group, formed in 2017 through the merger of Janus Capital Group (founded 1969) and Henderson Group (founded 1934), is a global asset management firm headquartered in London, managing over $350 billion in assets as of late 2024 for institutional, retail, and high-net-worth clients. With a strong presence in the U.S., Europe, and Asia-Pacific, the firm offers a wide range of investment products, including equities, fixed income, multi-asset, and alternative strategies, often blending active management with research-driven insights. Known for its equity expertise from Janus’s growth-focused heritage and Henderson’s European fixed-income strengths, Janus Henderson serves clients through mutual funds, ETFs, and bespoke portfolios, emphasizing risk-adjusted returns and ESG integration. Led by CEO Ali Dibadj since 2022, the publicly traded firm (NYSE: JHG) continues to refine its strategy amid competitive pressures, maintaining a foothold in key markets worldwide.
Top Buys
| 1 |
Microsoft
MSFT
|
$7.54B |
| 2 |
Alphabet (Google) Class C
GOOG
|
$6.14B |
| 3 |
Apple
AAPL
|
$5.11B |
| 4 |
Amazon
AMZN
|
$2.93B |
| 5 |
UnitedHealth
UNH
|
$2.83B |
Top Sells
| 1 |
ZEN
ZENDESK INC
ZEN
|
$330M |
| 2 |
Snap
SNAP
|
$321M |
| 3 |
Twilio
TWLO
|
$309M |
| 4 |
GBT
Global Blood Therapeutics, Inc.
GBT
|
$156M |
| 5 |
AVLR
Avalara, Inc.
AVLR
|
$154M |
Sector Composition
| 1 | Technology | 29.71% |
| 2 | Healthcare | 21.23% |
| 3 | Financials | 11.2% |
| 4 | Consumer Discretionary | 10.46% |
| 5 | Industrials | 9.73% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
76
Teleflex
TFX
$5.56B
| $852M | 0.32% |
4,227,352
+2,288,580
| +118% | +$461M |
|
77
Globus Medical
GMED
$7.97B
| $839M | 0.31% |
14,084,384
+7,385,176
| +110% | +$440M |
|
78
Caesars Entertainment
CZR
$5.33B
| $837M | 0.31% |
25,953,154
+14,831,391
| +133% | +$478M |
|
79
Wabtec
WAB
$32.7B
| $821M | 0.31% |
10,093,078
+5,016,455
| +99% | +$408M |
|
80
Corteva
CTVA
$49.7B
| $809M | 0.3% |
14,148,810
+9,537,237
| +207% | +$545M |
|
81
Marvell Technology
MRVL
$54.5B
| $800M | 0.3% |
18,636,650
+9,066,203
| +95% | +$389M |
|
82
Ascendis Pharma
ASND
$12.2B
| $792M | 0.3% |
7,673,516
+3,812,257
| +99% | +$394M |
|
83
DexCom
DXCM
$30.1B
| $787M | 0.29% |
9,772,042
+3,676,314
| +60% | +$296M |
|
84
Steris
STE
$23.7B
| $781M | 0.29% |
4,694,826
+2,332,505
| +99% | +$388M |
|
85
Global Payments
GPN
$20.9B
| $764M | 0.29% |
7,067,304
+3,437,598
| +95% | +$371M |
|
86
Meta Platforms (Facebook)
META
$1.85T
| $763M | 0.29% |
5,626,282
+973,945
| +21% | +$132M |
|
87
Starbucks
SBUX
$98.7B
| $761M | 0.28% |
9,026,038
+4,249,017
| +89% | +$358M |
|
88
Costco
COST
$416B
| $756M | 0.28% |
1,600,846
+542,472
| +51% | +$256M |
|
89
ICU Medical
ICUI
$3.11B
| $755M | 0.28% |
5,014,918
+2,466,590
| +97% | +$371M |
|
|
HZNP
90
DELISTED
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
| $747M | 0.28% |
12,074,036
+4,637,426
| +62% | +$287M |
|
|
MMP
91
DELISTED
Magellan Midstream Partners, L.P.
MMP
| $746M | 0.28% |
15,698,734
+7,978,426
| +103% | +$379M |
|
92
ConocoPhillips
COP
$119B
| $739M | 0.28% |
7,218,600
+5,083,754
| +238% | +$520M |
|
93
Aon
AON
$80.2B
| $724M | 0.27% |
2,700,804
+1,237,823
| +85% | +$332M |
|
94
Synopsys
SNPS
$109B
| $723M | 0.27% |
2,365,932
+1,184,532
| +100% | +$362M |
|
95
Sensata Technologies
ST
$4.62B
| $721M | 0.27% |
19,341,568
+9,441,478
| +95% | +$352M |
|
96
Howmet Aerospace
HWM
$69.8B
| $721M | 0.27% |
23,303,024
+12,799,344
| +122% | +$396M |
|
97
Freeport-McMoran
FCX
$65.7B
| $707M | 0.26% |
25,878,278
+12,049,242
| +87% | +$329M |
|
98
Dollar General
DG
$24.1B
| $701M | 0.26% |
2,923,124
+1,208,822
| +71% | +$290M |
|
99
Monster Beverage
MNST
$61.5B
| $701M | 0.26% |
8,062,422
+3,752,179
| +87% | +$326M |
|
100
BioMarin Pharmaceuticals
BMRN
$11.4B
| $700M | 0.26% |
8,259,448
+4,058,215
| +97% | +$344M |
|